Drug points: Neutropenia caused by intravenous immunoglobulin
نویسندگان
چکیده
منابع مشابه
Drug induced aseptic meningitis caused by intravenous immunoglobulin therapy.
Drug induced aseptic meningitis (DIAM) is an uncommon condition that can mimic infective conditions. DIAM has been recognized with various treatments including non-steroidal anti-inflammatory drugs, monoclonal antibodies and some antibiotics. We report a patient presenting with aseptic meningitis forty-eight hours after commencing a course of intravenous immunoglobulin (IVIG) treatment. It is i...
متن کاملNeutropenia Following Intravenous Immunoglobulin Therapy in Pediatric Patients with Idiopathic Thrombocytopenic Purpura
Background: Children with idiopathic thrombocytopenic purpura who are treated with intravenous immunoglobulin therapy might experience a decline in their absolute neutrophil count. The aim of this study was to investigate the incidence of neutropenia following intravenous immunoglobulin therapy in children with idiopathic thrombocytopenic purpura undergoing intravenous immunoglobulin therapy. ...
متن کاملIntravenous immunoglobulin therapy for hyperbilirubinemia caused by Rhesus hemolytic disease.
A nine-hour-old term small for date male newborn weighing 1850 g delivered by Cesarean section to an 'A' rhesus negative mother with an Rh antibody titre of 1:128, presented with pallor, icterus and mild hepatomegaly. Cord blood reports revealed an indirect serum bilirubin of 3.7 mg/dl, reticulocyte count 9%, platelet count 120,000/cu mm, hemoglobin (Hb) 9.3 g/dl, a positive direct Coomb's test...
متن کاملUses of intravenous immunoglobulin
Adjuvant high dose IVIgs are being used increasingly in a range of immune-mediated and auto-immune diseases. Although numerous immunomodulatory mechanisms have been suggested, the exact mechanisms of action are poorly understood. The efficacy of IVIg in certain diseases has been proven in clinical trials, in so far as IVIg is approved as the therapy of choice for Kawasaki syndrome and idiopathi...
متن کاملIntravenous immunoglobulin reduces beta amyloid and abnormal tau formation caused by herpes simplex virus type 1
Intravenous immunoglobulin (IVIG) treatment of Alzheimer's disease (AD) has been encouraging. Its mechanism of action might be via anti-β-amyloid (Aβ) antibodies which facilitate Aβ clearance. However, IVIG's benefits might result from its antiviral activity, particularly against herpes simplex virus type 1 (HSV1), a virus implicated in AD. We investigated IVIG's effect on HSV1, specifically on...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1988
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.296.6631.1262-a